Insmed Incorporated Logo

Insmed Incorporated

🇺🇸
INSM
US4576693075

Insmed Incorporated is a global US-based biopharmaceutical company dedicated to developing and commercializing innovative medicines for patients with rare and severe diseases. Its portfolio features treatments for specific lung diseases and neuromuscular disorders, addressing significant unmet medical needs.

Next Quarterly Earnings

Thursday, July 30, 2026
CW 31
Pre-Market
In 25 days

Stock Price

All Dates

Company Information

Name
Insmed Incorporated
Ticker Symbol
INSM
ISIN
US4576693075
Country
🇺🇸
USA